Skip to content

Clinical trials

Phase 1/2 Small Cell Lung Carcinoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 1/2 Country / region: Australia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20142
20151
20171
20204
20211
20231
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Completed4
Active, not recruiting2
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
AbbVie1
Ascentage Pharma Group Inc.1
BioNTech SE1
Bristol-Myers Squibb1
DualityBio Inc.1
Impact Therapeutics, Inc.1
Incyte Biosciences International Sàrl1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma16
Carcinoma, Non-Small-Cell Lung6
Melanoma4
Breast Neoplasms3
Colorectal Neoplasms3
Ovarian Neoplasms3
Prostatic Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Stomach Neoplasms3
Triple Negative Breast Neoplasms3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.